...
首页> 外文期刊>AJR: American Journal of Roentgenology : Including Diagnostic Radiology, Radiation Oncology, Nuclear Medicine, Ultrasonography and Related Basic Sciences >Apparent diffusion coefficient as a predictive biomarker of prostate cancer progression: value of fast and slow diffusion components.
【24h】

Apparent diffusion coefficient as a predictive biomarker of prostate cancer progression: value of fast and slow diffusion components.

机译:视扩散系数作为前列腺癌进展的预测生物标志物:快速和缓慢扩散成分的价值。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

OBJECTIVE: The purpose of our study was to investigate whether fast and slow components of the apparent diffusion coefficient (ADC) from diffusion-weighted MR images could predict prostate cancer progression in patients managed by active surveillance. SUBJECTS AND METHODS: Eighty-one patients managed by active surveillance underwent diffusion-weighted MRI in addition to T2-weighted MRI using an endorectal technique. ADCs from tumor regions of interest were calculated using all b values (ADC(all)), b = 0-300 s/mm(2) (ADC(fast)), and b = 300-800 s/mm(2) (ADC(slow)). These parameters and tumor volumes were compared in those upgraded at subsequent biopsy (n = 14) versus those histologically stable (n = 41) and in evaluable patients who progressed to radical treatment (n = 16) versus those who did not (n = 64). Cox's regression was used to analyze the effect of parameter mean on time to treatment. RESULTS: ADC(all), ADC(fast), and ADC(slow) in patients upgraded on repeat biopsy were significantly lower than those who were stable (1,070 +/- 110 vs 1,356 +/- 357 x 10(-6)mm(2)/s, p < 0.001; 1,283 +/- 188 vs 1,526 +/- 397 x 10(-6)mm(2)/s, p = 0.004; 843 +/- 74 vs 1,105 +/- 285 x 10(-6) mm(2)/s, p < 0.001, respectively). Tumor volume was significantly higher in the upgraded group (0.86 +/- 0.9 vs 0.26 +/- 0.25 cm(3), p = 0.02). The lower ADC(slow) in patients who subsequently progressed to radical treatment approached significance (922 +/- 256 vs 1,054 +/- 235 x 10(-6) mm(2)/s, p = 0.053; hazard ratio, 0.991 for time to treatment). Tumor volume was significantly higher in the treated group (0.86 +/- 0.85 cm(3) vs 0.32 +/- 0.33 cm(3), p = 0.02). ADC(slow) and tumor volume were significant but independent predictors of upgrade on biopsy (p = 0.01 and 0.002, respectively). CONCLUSION: Both fast and slow diffusion components were significantly lower in tumors that were subsequently upgraded on histology. Both tumor volume and the true diffusion ADC(slow) were significant but independent predictors of histologic progression.
机译:目的:本研究的目的是调查扩散加权MR图像中表观扩散系数(ADC)的快慢成分是否可以预测主动监测管理的患者的前列腺癌进展。研究对象和方法:通过直肠内检查,除T2加权MRI外,还接受了主动监测管理的81例患者进行了弥散加权MRI。使用所有b值(ADC(all)),b = 0-300 s / mm(2)(ADC(fast))和b = 300-800 s / mm(2)计算感兴趣肿瘤区域的ADC(b ADC(慢))。将这些参数和肿瘤体积在随后的活检中升级的患者(n = 14)与组织学稳定的患者(n = 41)进行了比较,在接受根治性治疗的可评估患者(n = 16)与未进行根治性治疗的患者(n = 64)中进行了比较。 )。使用Cox回归分析参数均值对治疗时间的影响。结果:经过反复活检的患者ADC(all),ADC(fast)和ADC(slow)显着低于稳定患者(1,070 +/- 110 vs 1,356 +/- 357 x 10(-6)mm (2)/ s,p <0.001; 1,283 +/- 188与1,526 +/- 397 x 10(-6)mm(2)/ s,p = 0.004; 843 +/- 74与1,105 +/- 285 x 10(-6)mm(2)/ s,p <0.001)。升级组的肿瘤体积明显更高(0.86 +/- 0.9 vs 0.26 +/- 0.25 cm(3),p = 0.02)。随后进行根治性治疗的患者中较低的ADC(慢)接近显着性(922 +/- 256 vs 1,054 +/- 235 x 10(-6)mm(2)/ s,p = 0.053;危险比,0.991治疗时间)。治疗组的肿瘤体积明显更高(0.86 +/- 0.85 cm(3)比0.32 +/- 0.33 cm(3),p = 0.02)。 ADC(缓慢)和肿瘤体积是重要的,但是活检升级的独立预测因子(分别为p = 0.01和0.002)。结论:在随后进行组织学升级的肿瘤中,快速扩散成分和缓慢扩散成分均显着降低。肿瘤体积和真实扩散ADC(slow)均是重要但独立的组织学进展预测因子。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号